Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04416685
What this trial is testing

A New Anatomical Classification of Portal Vein Location of Pancreas Tumors

Who this might be right for
Pancreatic Neoplasm Malignant Head Primary
Sisli Hamidiye Etfal Training and Research Hospital 43
Not applicableStudy completedNCT03949933
What this trial is testing

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
Shanghai Proton and Heavy Ion Center 10
Not applicableLooking for participantsNCT07272187
What this trial is testing

Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions

Who this might be right for
Insulinoma; PancreasMEN1NETs+3 more
Herlev Hospital 138
Not applicableEnrolling By InvitationNCT06076252
What this trial is testing

Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary Carcinoma

Who this might be right for
Ampullary CancerBile Duct CancerPancreas Cancer+1 more
Affiliated Hospital of Guangdong Medical University 150
Early research (Phase 1)Ended earlyNCT04117958
What this trial is testing

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

Who this might be right for
MUC17-positive Solid Tumors
Amgen 58
Early research (Phase 1)Study completedNCT02643498
What this trial is testing

A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center 11
Not applicableStudy completedNCT01774643
What this trial is testing

Pancreatic Cancer in Xenografts From Liver Metastases

Who this might be right for
Pancreatic CancerLiver MetastasesTumor Tissue Biopsy+1 more
University Health Network, Toronto 31
Testing effectiveness (Phase 2)Ended earlyNCT03136406
What this trial is testing

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00558207
What this trial is testing

Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 43
Early research (Phase 1)Looking for participantsNCT05877599
What this trial is testing

NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Who this might be right for
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more
AstraZeneca 45
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Testing effectiveness (Phase 2)Ended earlyNCT01413087
What this trial is testing

Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreas, Adenocarcinoma
Anchiano Therapeutics Israel Ltd. 12
Not applicableUnknownNCT04085055
What this trial is testing

Fine Needle Biopsy of Solid Pancreatic Mass Lesions

Who this might be right for
Pancreatic Neoplasms
AdventHealth 130
Early research (Phase 1)Ended earlyNCT00658801
What this trial is testing

Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Center, Korea 4
Early research (Phase 1)Active Not RecruitingNCT06818812
What this trial is testing

Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Who this might be right for
Solid Tumors
Incyte Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00398086
What this trial is testing

Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Celgene 67
Testing effectiveness (Phase 2)UnknownNCT06080854
What this trial is testing

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 108
Early research (Phase 1)Study completedNCT04132505
What this trial is testing

Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT06571461
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
CSPC Ouyi Pharmaceutical Co., Ltd. 408
Early research (Phase 1)Study completedNCT00925769
What this trial is testing

ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 32
Next Page